Idéal Investisseur
Français English
CAC 40 : Market open
8 023,54 pts
-0.41%


Last updated : 12/05/2026 - 13h06
🏠 Home   ➤    Stock news

EssilorLuxottica Shares Slide to €164.15, Hitting a New Low for 2023

The stock of the Franco-Italian optical giant drops 1.71% to €164.15 mid-morning, marking a new unprecedented low since 2023. The share price touched €162.50 during the session, below the previous low of €165.75 set in 2023. The session is unfolding in a CAC 40 down by 0.63% at 8,005.89 points.


EssilorLuxottica Shares Slide to €164.15, Hitting a New Low for 2023

A New Three-Year Low for the Stock

EssilorLuxottica ranks among the top five declines in the CAC 40 this Tuesday, positioned 37th out of 40 stocks. The stock continues a deep bearish sequence: down 5.25% over the week and 34.55% over three months. Over a year, the decline reaches 32.25%. The session low of €162.50 breaks the successive lows of recent weeks. On May 5th, the stock had set a two-year low at €170.40, already described as a significant low point. The breach of the €167 threshold (identified as support) intensifies the downward movement. A rebound attempt to €177.55 last week failed, with the stock quickly losing regained levels.

Marked Technical Overselling, Next Meeting on July 28

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

The share price is moving at the lower end of the Bollinger Bands, near the lower limit at €159.62. An RSI at 27 indicates a clear oversold condition. The MM50 (€198.45) remains 17.28% above the current price, illustrating the extent of the deviation from the medium-term dynamic. The sectoral context provides no support: discretionary consumer stocks are performing inconsistently, with Kering and LVMH respectively up by 1.19% and 0.92%, while EssilorLuxottica continues another session in the red. Operational growth remains solid, however: the group had posted at the end of April a quarterly revenue increase of 10.8% at constant rates, totaling €7.127 billion. The next key date is set for July 28, 2026, with the semi-annual results.



Sector Luxe Fournitures Médicales


Assurance vie

Context

Period
  • Period: 1T2026
Key reported figures
  • Revenue: 7127M€
Guidance from the release
  • Avec ce troisième trimestre consécutif de croissance à deux chiffres...
  • Chiffre d'affaires en hausse de +10,8 % au T1 2026.
Risks mentioned
  • Environnement incertain qui pourrait affecter la dynamique.
  • Pressions dans le secteur de la santé visuelle.
Opportunities identified
  • Lancement réussi des nouveaux modèles optiques Ray-Ban Meta.
  • Expansion du réseau de distribution avec l'investissement en Thaïlande.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit